TVTX logo
TVTX NASDAQ US

Travere Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jul 2003
$30.44
▼ $-0.98 (-3.12%)
Vol 1.1M
6
Quality Score
fail
Mkt Cap
$3.4B
ROE
-178.7%
Margin
-20.3%
D/E
423.26
Beta
0.83
52W
$13–$42

Wall Street Consensus

21 analysts · Apr 2026
8
Strong Buy
10
Buy
3
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

ARQT
Arcutis Biotherapeutics Inc
$3.6B
VERA
Vera Therapeutics, Inc
$3.5B
IDYA
IDEAYA Biosciences Inc
$3.0B
ORKA
Oruka Therapeutics Inc
$1.5B
VCYT
Veracyte Inc
P/E 110.3
$3.3B
BEAM
Beam Therapeutics Inc
$2.8B
IRON
Disc Medicine Inc
$3.0B
KOD
Kodiak Sciences Inc
$1.7B
IMNM
Immunome Inc
$2.4B

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.12 $0.03 +$0.15
Sep 2025 $-0.21 $0.28 +$0.49
Jun 2025 $-0.30 $-0.14 +$0.16
Mar 2025 $-0.55 $-0.47 +$0.08

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -275.0% -275.0% -275.0% -178.7% -178.7% -178.7%
P/E (TTM) — — — — — —
Net Margin -11.1% -50.6% -50.6% -20.3% -20.3% -20.3%
Gross Margin 98.7% 96.9% 96.9% 97.6% 97.6% 97.6%
D/E Ratio 1159.97 1159.97 1159.97 423.26 423.26 423.26
Current Ratio 2.00 2.00 2.00 2.75 2.75 2.75

Key Ratios

ROA (TTM)
-15.8%
P/S (TTM)
7.84
P/B
25.3
EPS (TTM)
$-1.08
CF/Share
$-4.45
Rev Growth 3Y
+0.8%
52W High
$42.13
52W Low
$12.91
$12.91 52-Week Range $42.13

How does TVTX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

TVTX AAPG ABEO ABOS ABP

TVTX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
7.8
▼ 39% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
25.3
▲ 928% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

TVTX profitability vs Biotechnology peers

ROE
-178.7%
▼ 165% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-20.3%
▲ 93% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
97.6%
▲ 24% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-15.8%
▲ 66% above peers (-46.7%)
vs Peers
vs Industry
Top tier

TVTX financial health vs Biotechnology peers

D/E ratio
423.3
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
2.8
▼ 38% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.8
▼ 14% below peers (1.0)
vs Peers
vs Industry
Less volatile

TVTX fundamentals radar

TVTX Peer median Industry

TVTX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

TVTX vs peers: key metrics

Latest News

No related news yet